- Type
- not stated
- Format
- Multimodal: tabular consignment and dose-scheduling records joined to temperature/shipping-container sensor time-series, GPS/route traces, cross-border customs event logs, and proof-of-administration/proof-of-specimen-receipt timestamps; exchange with orchestration platforms via structured integration feeds
- Volume
- ~10^6-10^7 consignments lifetime across the clinical logistics book, of which the radioligand-therapy subset is roughly 10^4-10^5 patient-dose closed-loop records — each one linking an order, a preconditioned container, a manufacturing pack event, a route, an administration timestamp and a return specimen (inferred from a $972M revenue band at specialist clinical courier rates, with RPT being a small but rapidly growing share)
- Users
- N/A as a consumer metric — institutional logistics operator; approximately 2,000-4,000 operational platform users across its ~4,000-person workforce (inferred from a $972M-revenue, 4,000-employee global carrier whose staff must work in validated tracking systems for every consignment)
- History
- 20 years
- Update frequency
- not stated
- Growth
- Active — radiopharma is presented as a dedicated current solution line with an actively published insight/thought-leadership programme on radiopharmaceutical logistics precision, positioned explicitly against a growing radioligand-therapy market; company is post-transaction with growth-capital backing
- Launched
- ~1960s-1980s for the underlying clinical-specimen courier franchise (inferred: a business of this scale with a $520M recorded funding/M&A history and an established global network predates the modern biologics era), with the dedicated radiopharma/RPT line a much later addition, ~2015-2020, driven by targeted-radiation therapies reaching commercial scale
- Delivery
- not stated
- Entity mapping
- not stated
- Sample
- not stated
- Point-in-time
- not stated
- Licence
- not stated